Clinical Trial Update: Patients With High-grade Pancreatic Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update indicating enrollment by invitation for patients with high-grade pancreatic neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Neuroendocrine Tumor of Pancreas, Pancreatic Neuroendocrine Tumors | Phase 2 | Status: ENROLLING_BY_INVITATION